Michael Georgetson, MD

  • Clinical Details
  • Education
  • News & Video
  • Clinical Trials
Hospital Privileges: 
  • Guthrie Corning Hospital
  • Guthrie Robert Packer Hospital
  • Guthrie Troy Community Hospital
Clinical Interests: 
  • Dysphagia
  • ERCP
  • Esophageal Diseases
  • Gastrointestinal Bleeding
  • Gastrointestional Neoplasia
Certification: 
  • American Board of IM/Gastroenterology
Education: 
  • Jefferson Medical College, Philadelphia, Pa.
Residency: 
  • Robert Packer Hospital, Sayre, Pa.
Fellowship: 
  • Robert Packer Hospital, Sayre, Pa.
  • Fellow of the American College of Gastroenterology (FACG)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Crohn's
Principal Investigator: Georgetson M.D., Michael
Sponsor: Salix
Indentifier #: NCT02240121
Title: A Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Multiregional Study to Assess the Efficacy and Safety of Rifaximin Delayed Release Tablets for the Induction and Maintenance of Remission in Subjects with Active Moderate Crohn's Disease (RECD3125)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01458574
Title:
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01470612
Title:
Department: Gastroenterology
Diagnosis: Gastrointestinal - Crohn's
Principal Investigator: Georgetson M.D., Michael
Sponsor: Salix
Indentifier #: NCT02240121
Title:
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01458951
Title: A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS AN INDUCTION THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01458574
Title: A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS A MAINTENANCE THERAPY IN SUBJECTS WITH ULCERATIVE COLITIS
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01470612
Title: A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01458574
Title: A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS A MAINTENANCE THERAPY IN SUBJECTS WITH ULCERATIVE COLITIS
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01470612
Title: A MULTI-CENTER, OPEN-LABEL STUDY OF CP-690,550 IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sponsor: Pfizer
Indentifier #: NCT01458951
Title: A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS AN INDUCTION THERAPY IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS